CAS 10326-41-7|D-(−)-Lactic acid
| Common Name | D-(−)-Lactic acid | ||
|---|---|---|---|
| CAS Number | 10326-41-7 | Molecular Weight | 90.078 |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 227.6±0.0 °C at 760 mmHg |
| Molecular Formula | C3H6O3 | Melting Point | / |
| MSDS | ChineseUSA | Flash Point | 109.9±16.3 °C |
| Symbol | GHS05 | Signal Word | Danger |
Names
| Name | (R)-lactic acid |
|---|---|
| Synonym | More Synonyms |
D-(−)-Lactic acid BiologicalActivity
| Description | D-(-)-Lactic acid is a normal intermediate in the fermentation (oxidation, metabolism) of sugar. |
|---|---|
| Related Catalog | Natural Products >>Acids and AldehydesResearch Areas >>Metabolic Disease |
| Target | Human Endogenous Metabolite |
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 227.6±0.0 °C at 760 mmHg |
| Molecular Formula | C3H6O3 |
| Molecular Weight | 90.078 |
| Flash Point | 109.9±16.3 °C |
| Exact Mass | 90.031693 |
| PSA | 57.53000 |
| LogP | -0.70 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.451 |
| InChIKey | JVTAAEKCZFNVCJ-UWTATZPHSA-N |
| SMILES | CC(O)C(=O)O |
| Storage condition | 2-8°C |
| Water Solubility | H2O: 0.1 g/mL, clear, colorless |
Safety Information
| Symbol | GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H315-H318 |
| Precautionary Statements | P280-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi:Irritant |
| Risk Phrases | R38;R41 |
| Safety Phrases | S26-S39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2918199090 |
Customs
| HS Code | 2918199090 |
|---|---|
| Summary | 2918199090 other carboxylic acids with alcohol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |
Articles35
More Articles| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). J. Sci. Ind. Res. 65(10) , 808, (2006) Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ... | |
| Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin. Chem. 30(3) , 426-32, (1984) Numerous low-Mr metabolites--including creatinine, citrate, hippurate, glucose, ketone bodies, and various amino acids--have been identified in 400- and 500-MHz proton nuclear magnetic resonance (1H N... | |
| 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 29(6) , 1214-9, (2006) Postprandial hyperglycemia is often inadequately assessed in diabetes management. Serum 1,5-anhydroglucitol (1,5-AG) drops as serum glucose rises above the renal threshold for glucose and has been pro... |
Synonyms
| D-(−)-Lactic acid |
| D(-)-Lactic Acid |
| Propanoic acid, 2-hydroxy-, (2R)- |
| MFCD00068311 |
| d-LACTIC ACID |
| (-)-lactic acid |
| (R)-(-)-lactic acid |
| Lactic acid, D- |
| (D)-(-)-Lactic acid |
| R-lactic acid |
| (R)-2-Hydroxypropanoic acid |
| δ-Lactic acid |
| D-lactate |
| EINECS 233-713-2 |
| (R)-2-Hydroxypropionic acid |
| (2R)-2-Hydroxypropanoic acid |
| (R)-a-Hydroxypropionic acid |
| L-Lactic acid |
| Lactic acid |
